申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20160251309A1
公开(公告)日:2016-09-01
Disclosed are compounds of Formula (I)
and/or a salt thereof; wherein R is —OH or —OP(O)(OH)
2
. Also disclosed are methods of using such compounds as selective agonists for G protein-coupled receptor S1P
1
, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.
本发明涉及公式(I)及/或其盐的化合物;其中R为—OH或—OP(O)(OH)2。本发明还涉及使用这些化合物作为选择性G蛋白偶联受体S1P1的激动剂的方法,以及包含这些化合物的药物组合物。这些化合物在多种治疗领域中有用,例如自身免疫疾病和血管疾病,可用于治疗、预防或减缓疾病或障碍的进展。